These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15530764)

  • 21. Family-based screening for colorectal cancer: The Australian perspective.
    Leggett BA
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial colorectal cancer].
    Sunde LE; Bülow S; Bernstein IT
    Ugeskr Laeger; 2006 Jun; 168(24):2369-73. PubMed ID: 16822423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic testing in gastroenterology: Lynch syndrome.
    Grover S; Syngal S
    Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP.
    Ramsoekh D; van Leerdam ME; Tops CM; Dooijes D; Steyerberg EW; Kuipers EJ; Wagner A
    Clin Genet; 2007 Dec; 72(6):562-7. PubMed ID: 17922849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psychosocial consequences of genetic susceptibility on development of disease].
    Tobiasz-Adamczyk B
    Przegl Lek; 2005; 62(12):1521-4. PubMed ID: 16786787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk.
    Wakefield CE; Homewood J; Mahmut M; Taylor A; Meiser B
    Patient Educ Couns; 2007 Dec; 69(1-3):29-38. PubMed ID: 17706910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
    O'Neill SC; DeMarco T; Peshkin BN; Rogers S; Rispoli J; Brown K; Valdimarsdottir H; Schwartz MD
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):251-9. PubMed ID: 17024668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term impact of Huntington disease linkage testing.
    Taylor CA; Myers RH
    Am J Med Genet; 1997 Jun; 70(4):365-70. PubMed ID: 9182776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
    Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.